Federated Hermes, Inc. Personalis, Inc. Transaction History

Federated Hermes, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.78 - $3.64 $2,475 - $5,063	1,391 Added 88.32%	2,966 $5,000
Q3 2022 Nov 14, 2022	SELL	$2.89 - $5.32 $3,505 - $6,453	-1,213 Reduced 43.51%	1,575 $5,000
Q2 2022 Aug 15, 2022	BUY	$3.27 - $8.76 $9,116 - $24,422	2,788 New	2,788 $10,000
Q1 2021 May 13, 2021	SELL	$20.71 - $51.02 $4.5 Million - $11.1 Million	-217,169 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$21.84 - $44.0 $440,207 - $886,864	20,156 Added 10.23%	217,169 $7.95 Million
Q3 2020 Nov 12, 2020	BUY	$13.63 - $24.12 $2.55 Million - $4.51 Million	187,013 Added 1870.13%	197,013 $4.27 Million
Q2 2020 Aug 13, 2020	SELL	$7.65 - $14.11 $382,500 - $705,500	-50,000 Reduced 83.33%	10,000 $130,000
Q1 2020 May 13, 2020	BUY	$4.75 - $12.41 $142,500 - $372,300	30,000 Added 100.0%	60,000 $484,000
Q4 2019 Feb 14, 2020	BUY	$8.73 - $12.95 $130,950 - $194,250	15,000 Added 100.0%	30,000 $327,000
Q3 2019 Nov 14, 2019	SELL	$14.16 - $25.34 $70,800 - $126,700	-5,000 Reduced 25.0%	15,000 $220,000
Q2 2019 Aug 14, 2019	BUY	$27.0 - $30.25 $540,000 - $605,000	20,000 New	20,000 $543,000

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $171M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.